Friday, November 6, 2009

Has Genta's Energizer Bunny of Cancer Drugs Finally Run Out of Juice?

The most surprising thing about last week’s Phase III failure of beleaguered cancer drug Genasense was that Genta’s stock (GETA.OB) fell 70 percent. Seriously, who didn’t see this one coming? Read More
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)